Anti-Diabetic Retinopathy Molecular Mechanism of Dihuang Yinzi: Insights from Network Pharmacology, Metabolomics, and Microbiome Analysis - Top-Institutions - MDSpire

Anti-Diabetic Retinopathy Molecular Mechanism of Dihuang Yinzi: Insights from Network Pharmacology, Metabolomics, and Microbiome Analysis

  • By

  • Chai, Jinmiao

  • Gui, Wanwei

  • Zhang, Junlong

  • He, Wenbin

  • Li, Qinqing

  • April 28, 2026

  • 0 min

Share

Top Institutions in Ophthalmology

Brief introduction explaining scope and methodology.

  • #1

    Harvard Ophthalmology – Massachusetts Eye and Ear
    Harvard Ophthalmology – Massachusetts Eye and Ear

    Boston, Massachusetts

    Key Differentiators

    • Ophthalmology
    • Retina

  • #2

    Wilmer Eye Institute, Johns Hopkins University
    Wilmer Eye Institute, Johns Hopkins University

    Baltimore, Maryland

    Key Differentiators

    • Ophthalmology
    • Retina

  • #3

    Beijing Hospital of Traditional Chinese Medicine
    Beijing Hospital of Traditional Chinese Medicine

    Beijing, Beijing

    Key Differentiators

    • Traditional Chinese Medicine
    • Ophthalmology

  • #4

    Bascom Palmer Eye Institute
    Bascom Palmer Eye Institute

    Miami, Florida

    Key Differentiators

    • Ophthalmology
    • Retina

  • #5

    Wills Eye Hospital
    Wills Eye Hospital

    Philadelphia, Pennsylvania

    Key Differentiators

    • Ophthalmology

Original Source(s)

Anti-Diabetic Retinopathy Molecular Mechanism of Dihuang Yinzi: Insights from Network Pharmacology, Metabolomics, and Microbiome Analysis

  • by Chai, Jinmiao , Gui, Wanwei , Zhang, Junlong , He, Wenbin , Li, Qinqing

  • April 28, 2026

Related Content

Retina Biomarkers for Treatment Selection in DME

A clinically interpretable machine learning model for early detection of diabetic retinopathy in multiple community health centers

Clinical Case Study: Post-Surgical Antiviral Intervention Following Pterygium Excision Informed by Corneal Confocal Microscopy